| KALA BIO, Inc. (KALA) |
| Q2-CY2026 | Q1-CY2026 | Q4-CY2025 | Q3-CY2025 | Q2-CY2025 | Q1-CY2025 | Q4-CY2024 | Q3-CY2024 | Q2-CY2024 | Q1-CY2024 | Q4-CY2023 | Q3-CY2023 | Q2-CY2023 | Q1-CY2023 | Q4-CY2022 | Q3-CY2022 | Q2-CY2022 | Q1-CY2022 | Q4-CY2021 | Q3-CY2021 | Q2-CY2021 | Q1-CY2021 | Q4-CY2020 | Q3-CY2020 | Q2-CY2020 | Q1-CY2020 | Q4-CY2019 | Q3-CY2019 | Q2-CY2019 | Q1-CY2019 | Q4-CY2018 | Q3-CY2018 | Q2-CY2018 | Q1-CY2018 | Q4-CY2017 | Q3-CY2017 | Q2-CY2017 | Q1-CY2017 | Q4-CY2016 | Q3-CY2016 | Q2-CY2016 | Q1-CY2016 | Q4-CY2015 | Q3-CY2015 | Q2-CY2015 | Q1-CY2015 | Q4-CY2014 | Q3-CY2014 | Q2-CY2014 |
| Balance Sheet Date | | | 2025-Dec-31 | 2025-Sep-30 | 2025-Jun-30 | 2025-Mar-31 | 2024-Dec-31 | 2024-Sep-30 | 2024-Jun-30 | 2024-Mar-31 | 2023-Dec-31 | 2023-Sep-30 | 2023-Jun-30 | 2023-Mar-31 | 2022-Dec-31 | 2022-Sep-30 | 2022-Jun-30 | 2022-Mar-31 | 2021-Dec-31 | 2021-Sep-30 | 2021-Jun-30 | 2021-Mar-31 | 2020-Dec-31 | 2020-Sep-30 | 2020-Jun-30 | 2020-Mar-31 | 2019-Dec-31 | 2019-Sep-30 | 2019-Jun-30 | 2019-Mar-31 | 2018-Dec-31 | 2018-Sep-30 | 2018-Jun-30 | 2018-Mar-31 | 2017-Dec-31 | 2017-Sep-30 | 2017-Jun-30 | | | | | | | | | | | | |
| Fiscal Period | | | Q4-FY2025 | Q3-FY2025 | Q2-FY2025 | Q1-FY2025 | Q4-FY2024 | Q3-FY2024 | Q2-FY2024 | Q1-FY2024 | Q4-FY2023 | Q3-FY2023 | Q2-FY2023 | Q1-FY2023 | Q4-FY2022 | Q3-FY2022 | Q2-FY2022 | Q1-FY2022 | Q4-FY2021 | Q3-FY2021 | Q2-FY2021 | Q1-FY2021 | Q4-FY2020 | Q3-FY2020 | Q2-FY2020 | Q1-FY2020 | Q4-FY2019 | Q3-FY2019 | Q2-FY2019 | Q1-FY2019 | Q4-FY2018 | Q3-FY2018 | Q2-FY2018 | Q1-FY2018 | Q4-FY2017 | Q3-FY2017 | Q2-FY2017 | | | | | | | | | | | | |
| Price to Sales | | | | | | | | | | | | 5.76x | 8.74x | 7.85x | 14.85x | 2.92x | 2.60x | 10.68x | 7.02x | 14.67x | 31.74x | 48.59x | 59.80x | 79.11x | 128.57x | 56.24x | 20.90x | | | | | | | | | | | | | | | | | | | | | | |
| Price to Book | .26x | .20x | .65x | - | - | 5.27x | 2.63x | 3.53x | 1.45x | 3.17x | 2.45x | 2.00x | 1.95x | 1.30x | 3.05x | - | - | - | 4.70x | 2.77x | 4.06x | 3.79x | 3.80x | 3.96x | 4.52x | 2.29x | 4.28x | 3.01x | 3.53x | 3.40x | 1.57x | 4.42x | 4.92x | 4.84x | 5.06x | 5.59x | | | | | | | | | | | | | |
| Price to Earnings | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | | | | | | | | | | | | | |
| Price to Unlevered FCF | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | | | | | | | | | | | | | | | | |
| Debt to Asset Ratio | | | .26x | 1.35x | 1.09x | .88x | .78x | .87x | .78x | .87x | .87x | .82x | .74x | .68x | .78x | 1.01x | 1.37x | 1.05x | .88x | .68x | .61x | .52x | .55x | .53x | .47x | .45x | .81x | .73x | .66x | .58x | .52x | .35x | .29x | .24x | .23x | .20x | .62x | | .34x | | | | | | | | | | |
| Current Ratio | | | 3.81x | .75x | 2.10x | 1.99x | 3.11x | 2.15x | 3.07x | 4.22x | 6.33x | 5.62x | 6.65x | 6.95x | 3.35x | 2.10x | 2.54x | 3.00x | 3.32x | 5.48x | 6.59x | 8.96x | 7.71x | 9.11x | 11.63x | 12.17x | 4.26x | 6.25x | 7.50x | 10.30x | 10.41x | 6.34x | 9.78x | 20.40x | 7.75x | 10.99x | 3.55x | | 8.23x | | | | | | | | | | |
✓